1.
J. Gambini, M. Inglés, C. Borras. Genética y
envejecimiento. Tratado de medicina geriátrica, pp. 142-154
2.
P. Sebastiani, N. Solovieff, A.T. Dewan, K.M. Walsh,
A. Puca, S.W. Hartley, et al.Genetic signatures of exceptional
longevity in humans. PLoS
One., 7 (2012), pp. e29848 http://dx.doi.org/10.1371/journal.pone.002984
3.
Del Llano et al. Genoma y Medicina (Internet). Genoma
España, 2004.
4.
Evans WE, McLeod HL. Pharmacogenomics – drug
disposition, drug targets, and side effects. N
Engl J Med 2003; 348:538-48.
6. Bredel M, Jacoby E.
Chemogenomics: an emerging strategy for rapid target and drug discovery. Nat
Rev Genet 2004; 5:262-75.
8.
Director, N.. National Human Genome Research Institute .
(31 de Agosto de 2019). Obtenido de https://www.genome.gov/es/genetics-glossary/Polimorfismos-de-nucleotido-%C3%BAnico
9.
Crawford
DC, Akey DT, Nickerson DA. The patterns of natural variation in human genes. Annu
Rev Genomics Genet 2005;6:287-312.
10.
Bird,
A. & Macleod, D. (2004) Reading the DNA methylation signal. Cold
Spring Harb. Symp. Quant. Biol. 69: 113-118.
11.
Bird,
A. DNA methylation patterns and epigenetic memory. Genes.
Dev. 2002, 16: 6-21.
12.
Esteller,
M. Aberrant DNA methylation as a cancerinducing mechanism. Annu.
Rev. Pharmacol. Toxicol. 2005, 45: 629-656.
13.
Esteller,
M. Cancer epigenomics: DNA methylomes and histone-modification maps. 2007,
8: 286-298.
14.
Wang,
Y., Wysocka, J., Perlin, J. R., Leonelli, L., Allis, C. D. & Coonrod, S. A.
Linking covalent histone modifications to epigenetics: the rigidity and
plasticity of the marks. Cold Spring Harb. Symp.
Quant. Biol. 2004, 69: 161-169.
15.
Jackson,D.
A., Symons, R. H. & Berg, P. Biochemical method for inserting new genetic
information into DNA of Simian Virus 40: circular SV40 DNA molecules containing
lambda phage genes and the galactose operon of Escherichia coli. Proc.Natl
Acad. Sci. USA 1972. 69, 2904–2909.
16.
Cohen,
S. N., Chang,A. C., Boyer, H.W. & Helling,R. B. Construction of
biologically functional bacterial plasmids in vitro. Proc.Natl
Acad. Sci. USA 1973. 70, 3240–3244
17.
The
International Human Genome Sequencing Consortium. Initial sequencing and
analysis of the human genome. Nature. 2001.
409, 860–921.
18.
Franco Agudelo
Saúl. El genoma humano y su impacto en la salud pública. Rev Cubana Salud
Pública [Internet]. 2003 Dic [citado 2019 Ago 31]
; 29( 4 ). Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-34662003000400010&lng=es.
19.
Jiménez Sánchez,
Gerardo. (2004). VII. El genoma humano. Implicaciones de la medicina genómica
en México. Gaceta médica de México, 140(2), 260-263.
Recuperado en 31 de agosto de 2019, de http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-38132004000200033&lng=es&tlng=es.
20.
Correa M. El valiente proyecto del genoma humano. Rev.
Saúde Coletiva, Rio de Janeiro. 2002, 12(2):277-299.
21.
Chadwick
R. Genomics, Public Health and Identity. Acta
Bioethica de Universidad de Chile, 9(2).2003. pp. 209-218.
22.
Daniel
N. Harris et al. Evolutionary genomic dynamics of Peruvians before, during, and
after the Inca Empire. Institute for Genome Sciences, University of Maryland
School of Medicine, Baltimore, MD 21201. 2017
23.
Burguete A, Bermúdez et
al. Medicina genómica aplicada a la
salud pública. Salud Publica Mex 2009;51 supl 3:S379-S385.
24.
Ramírez
J, Jiménez M. Functional implications of
single nucleotide polymorphisms (SNPs) in protein-coding and non-coding RNA genes
in multifactorial diseases. Research Unit on Metabolic
and Endocrine Disease, Hospital Juárez de México, Ciudad de México, Mexico.2017
25.
Thomas Van den Broeck et al.
The Role of Single Nucleotide
Polymorphisms in Predicting Prostate Cancer Risk and Therapeutic Decision
Making. Received 6 December 2013; Accepted 7 January
2014; Published 19 February 2014
Comentarios
Publicar un comentario